BRONCHOMALACIA

BRONCHOMALACIA was reported 132 times

These drug classes are most commonly taken by patients reporting BRONCHOMALACIA:

# Drug Count
0 Corticosteroid [EPC] 69
1 Thiazide Diuretic [EPC] 36
2 Nonsteroidal Anti-inflammatory Drug [EPC] 33
3 Serotonin Reuptake Inhibitor [EPC] 23
4 Platelet Aggregation Inhibitor [EPC] 22
5 Tumor Necrosis Factor Blocker [EPC] 22
6 Angiotensin Converting Enzyme Inhibitor [EPC] 19
7 Anti-IgE [EPC] 18
8 Proton Pump Inhibitor [EPC] 15
9 Interleukin-5 Antagonist [EPC] 12
10 Interleukin-6 Receptor Antagonist [EPC] 10
11 Purine Antimetabolite [EPC] 9
12 Selective T Cell Costimulation Modulator [EPC] 9
13 Loop Diuretic [EPC] 8
14 Tetracycline-class Drug [EPC] 8
15 Folate Analog Metabolic Inhibitor [EPC] 7
16 Insulin Analog [EPC] 6
17 Benzodiazepine [EPC] 5
18 Expectorant [EPC] 5
19 Osmotic Laxative [EPC] 5
20 Serotonin-3 Receptor Antagonist [EPC] 5
21 Vitamin C [EPC] 5
22 Dietary Cholesterol Absorption Inhibitor [EPC] 4
23 Vitamin B12 [EPC] 4
24 Vitamin D [EPC] 4
25 Anti-anginal [EPC] 3
26 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
27 Dihydropyridine Calcium Channel Blocker [EPC] 3
28 Non-Standardized Chemical Allergen [EPC] 3
29 beta-Adrenergic Blocker [EPC] 3
30 Angiotensin 2 Receptor Blocker [EPC] 2
31 Anti-epileptic Agent [EPC] 2
32 Calcium Channel Blocker [EPC] 2
33 Calcium [EPC] 2
34 Catecholamine [EPC] 2
35 HMG-CoA Reductase Inhibitor [EPC] 2
36 Histamine-2 Receptor Antagonist [EPC] 2
37 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2
38 Interleukin-4 Receptor alpha Antagonist [EPC] 2
39 Janus Kinase Inhibitor [EPC] 2
40 Nitroimidazole Antimicrobial [EPC] 2
41 Non-narcotic Antitussive [EPC] 2
42 Opioid Agonist [EPC] 2
43 Orexin Receptor Antagonist [EPC] 2
44 Polyene Antifungal [EPC] 2
45 Potassium Salt [EPC] 2
46 Provitamin D2 Compound [EPC] 2
47 alpha-Adrenergic Agonist [EPC] 2
48 beta-Adrenergic Agonist [EPC] 2
49 Aldosterone Antagonist [EPC] 1
50 Alkylating Drug [EPC] 1
51 Amide Local Anesthetic [EPC] 1
52 Aminoglycoside Antibacterial [EPC] 1
53 Antiarrhythmic [EPC] 1
54 Asparagine-specific Enzyme [EPC] 1
55 Atypical Antipsychotic [EPC] 1
56 Azole Antifungal [EPC] 1
57 CD20-directed Cytolytic Antibody [EPC] 1
58 CD52-directed Cytolytic Antibody [EPC] 1
59 Calcineurin Inhibitor Immunosuppressant [EPC] 1
60 Cannabinoid [EPC] 1
61 Central Nervous System Stimulant [EPC] 1
62 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
63 Ester Local Anesthetic [EPC] 1
64 Factor Xa Inhibitor [EPC] 1
65 Fluoroquinolone Antibacterial [EPC] 1
66 GLP-1 Receptor Agonist [EPC] 1
67 General Anesthetic [EPC] 1
68 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
69 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
70 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
71 Histamine-1 Receptor Antagonist [EPC] 1
72 Human Immunoglobulin G [EPC] 1
73 Interleukin-17A Antagonist [EPC] 1
74 Interleukin-23 Antagonist [EPC] 1
75 Kinase Inhibitor [EPC] 1
76 Leukotriene Receptor Antagonist [EPC] 1
77 Methylxanthine [EPC] 1
78 Mood Stabilizer [EPC] 1
79 Nitrate Vasodilator [EPC] 1
80 Nucleoside Metabolic Inhibitor [EPC] 1
81 Oxytocic [EPC] 1
82 P2Y12 Platelet Inhibitor [EPC] 1
83 Sigma-1 Agonist [EPC] 1
84 Sulfonamide Antimicrobial [EPC] 1
85 Thymic Stromal Lymphopoietin Blocker [EPC] 1
86 Tissue-nonspecific Alkaline Phosphatase [EPC] 1
87 Tyrosine Kinase 2 Inhibitor [EPC] 1
88 Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] 1
89 alpha-Adrenergic Blocker [EPC] 1
90 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
91 mTOR Inhibitor Immunosuppressant [EPC] 1